Jason Elliott

1.3k total citations
38 papers, 865 citations indexed

About

Jason Elliott is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jason Elliott has authored 38 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 21 papers in Molecular Biology and 12 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jason Elliott's work include Neuropeptides and Animal Physiology (12 papers), Chemical Synthesis and Analysis (10 papers) and Asymmetric Synthesis and Catalysis (9 papers). Jason Elliott is often cited by papers focused on Neuropeptides and Animal Physiology (12 papers), Chemical Synthesis and Analysis (10 papers) and Asymmetric Synthesis and Catalysis (9 papers). Jason Elliott collaborates with scholars based in United Kingdom, United States and Switzerland. Jason Elliott's co-authors include Richard F. W. Jackson, Stuart Warren, Duncan Shaw, Gary G. Chicchi, Charles E. Mowbray, Philip Magnus, Thomas Pitterna, Marc M. Kurtz, Christopher J. Swain and Gregory J. Hollingworth and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Jason Elliott

38 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason Elliott United Kingdom 17 640 311 86 70 63 38 865
Yong‐Jin Wu United States 19 714 1.1× 265 0.9× 69 0.8× 60 0.9× 98 1.6× 57 960
Hun Yeong Koh South Korea 21 792 1.2× 452 1.5× 105 1.2× 62 0.9× 119 1.9× 82 1.1k
Carla Marchioro Italy 17 598 0.9× 350 1.1× 102 1.2× 58 0.8× 45 0.7× 60 933
A. DA SETTIMO Italy 17 637 1.0× 348 1.1× 54 0.6× 37 0.5× 57 0.9× 64 841
Oleg D. Mitkin Russia 18 581 0.9× 294 0.9× 74 0.9× 28 0.4× 77 1.2× 63 835
Robert J. Mathvink United States 13 506 0.8× 191 0.6× 66 0.8× 31 0.4× 32 0.5× 19 737
Dieter Hamprecht United Kingdom 19 616 1.0× 337 1.1× 47 0.5× 57 0.8× 176 2.8× 37 961
James L. Stanton Switzerland 19 483 0.8× 424 1.4× 52 0.6× 64 0.9× 118 1.9× 27 891
Sean P. Hollinshead United States 16 483 0.8× 417 1.3× 82 1.0× 30 0.4× 155 2.5× 33 761
Paul E. Harrington United States 18 896 1.4× 363 1.2× 46 0.5× 101 1.4× 141 2.2× 31 1.2k

Countries citing papers authored by Jason Elliott

Since Specialization
Citations

This map shows the geographic impact of Jason Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Elliott more than expected).

Fields of papers citing papers by Jason Elliott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Elliott. The network helps show where Jason Elliott may publish in the future.

Co-authorship network of co-authors of Jason Elliott

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Elliott. A scholar is included among the top collaborators of Jason Elliott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Elliott. Jason Elliott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jelley, Richard A., Jason Elliott, Karl R. Gibson, et al.. (2006). 3-Substituted gem-cyclohexane sulfone based γ-secretase inhibitors for Alzheimer’s disease: Conformational analysis and biological activity. Bioorganic & Medicinal Chemistry Letters. 16(14). 3839–3842. 14 indexed citations
2.
Elliott, Jason, Emma Carlson, Gary G. Chicchi, et al.. (2006). NK1 antagonists based on seven membered lactam scaffolds. Bioorganic & Medicinal Chemistry Letters. 16(11). 2929–2932. 15 indexed citations
3.
Elliott, Jason, Robert W. Carling, Gary G. Chicchi, et al.. (2006). N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II. Bioorganic & Medicinal Chemistry Letters. 16(22). 5752–5756. 15 indexed citations
4.
Elliott, Jason, Robert W. Carling, Mark S. Chambers, et al.. (2006). N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(22). 5748–5751. 35 indexed citations
5.
Dirat, Olivier, et al.. (2006). Regioselective synthesis of 4-(2-alkyl-5-methyl-2H-pyrazol-3-yl)-piperidines. Tetrahedron Letters. 47(11). 1729–1731. 22 indexed citations
6.
Teall, Martin, Paul Oakley, Timothy Harrison, et al.. (2005). Aryl sulfones: a new class of γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(10). 2685–2688. 98 indexed citations
7.
Hollingworth, Gregory J., Emma Carlson, José L. Castro, et al.. (2005). Novel lactam NK1 antagonists with anti-emetic activity. Bioorganic & Medicinal Chemistry Letters. 16(5). 1197–1201. 1 indexed citations
8.
Porter, Michael J., et al.. (2005). Synthesis of Vinylogous Carbamates by Rhodium(II)-Catalyzed Olefination of Tertiary Formamides with a Silylated Diazoester. Organic Letters. 7(16). 3453–3455. 20 indexed citations
9.
Hop, Cornelis E. C. A., Yanfeng Wang, Sanjeev Kumar, et al.. (2002). Identification of Metabolites of a Substance P (Neurokinin 1 Receptor) Antagonist in Rat Hepatocytes and Rat Plasma. Drug Metabolism and Disposition. 30(8). 937–943. 6 indexed citations
10.
Carlson, Emma, José L. Castro, Gary G. Chicchi, et al.. (2002). 4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II. Bioorganic & Medicinal Chemistry Letters. 12(13). 1759–1762. 16 indexed citations
11.
Elliott, Jason, José L. Castro, Gary G. Chicchi, et al.. (2002). 4,4-Disubstituted cyclohexylamine NK1 receptor antagonists I. Bioorganic & Medicinal Chemistry Letters. 12(13). 1755–1758. 8 indexed citations
12.
Shaw, Duncan, Gary G. Chicchi, Jason Elliott, et al.. (2001). 2-Aryl indole NK1 antagonists: optimisation of the amide substituent. Bioorganic & Medicinal Chemistry Letters. 11(23). 3031–3034. 10 indexed citations
13.
Chicchi, Gary G., Jason Elliott, Gregory J. Hollingworth, et al.. (2001). 2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent. Bioorganic & Medicinal Chemistry Letters. 11(9). 1237–1240. 50 indexed citations
14.
Chicchi, Gary G., Jason Elliott, Gregory J. Hollingworth, et al.. (2001). 2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution. Bioorganic & Medicinal Chemistry Letters. 11(9). 1233–1236. 61 indexed citations
15.
Elliott, Jason, Margaret A. Cascieri, Gary G. Chicchi, et al.. (1998). Serine derived NK1 antagonists 1: The effect of modifications to the serine substituents. Bioorganic & Medicinal Chemistry Letters. 8(14). 1845–1850. 7 indexed citations
16.
Elliott, Jason, Howard B. Broughton, Margaret A. Cascieri, et al.. (1998). Serine derived NK1 antagonists 2: a pharmacophore model for arylsulfonamide binding. Bioorganic & Medicinal Chemistry Letters. 8(14). 1851–1856. 19 indexed citations
18.
19.
Carter, Paul, et al.. (1988). Organometallic chemistry can simplify the synthesis of important biologically active natural products. Philosophical Transactions of the Royal Society of London Series A Mathematical and Physical Sciences. 326(1592). 641–651. 1 indexed citations
20.
Elliott, Jason & Stuart Warren. (1986). Horner-Wittig reactions using dibenzophosphole oxides: Stereochemically controlled reduction of ketones. Tetrahedron Letters. 27(5). 645–648. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026